|
AKTIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.421700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.411830E-01 |
| Normal-vs-Stage2 |
1.642590E-01 |
| Normal-vs-Stage3 |
3.252300E-02 |
| Normal-vs-Stage4 |
3.196000E-03 |
| Stage1-vs-Stage2 |
8.018000E-01 |
| Stage1-vs-Stage3 |
2.364200E-01 |
| Stage1-vs-Stage4 |
1.620440E-01 |
| Stage2-vs-Stage3 |
3.987400E-01 |
| Stage2-vs-Stage4 |
1.322250E-01 |
| Stage3-vs-Stage4 |
5.287200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.019900E-02 |
| Normal-vs-AfricanAmerican |
1.774150E-01 |
| Normal-vs-Asian |
7.857800E-01 |
| Caucasian-vs-AfricanAmerican |
9.959200E-01 |
| Caucasian-vs-Asian |
8.965600E-01 |
| AfricanAmerican-vs-Asian |
8.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.255950E-02 |
| Normal-vs-Female |
7.498200E-01 |
| Male-vs-Female |
1.424780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.964920E-03 |
| Normal-vs-Extreme_Weight |
3.486400E-02 |
| Normal-vs-Obese |
4.725200E-01 |
| Normal-vs-Extreme_Obese |
7.510800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.486000E-01 |
| Normal_Weight-vs-Obese |
5.275700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.402200E-01 |
| Extreme_Weight-vs-Obese |
3.123600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.906600E-01 |
| Obese-vs-Extreme_Obese |
9.938000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.174200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.586000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.144200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.657700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.026800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.452200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.493200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.375800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.848400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.664800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.236400E-01 |
| Normal-VS-Type2 PRCC |
7.74820000000176E-05 |
| Normal-VS-KIRP CIMP |
9.336300E-02 |
| Normal-VS-Unclassified PRCC |
6.471800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.584400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.539200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.201200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.802600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.361800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.306600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.973830E-02 |
| Normal-vs-N1 |
1.740850E-03 |
| Normal-vs-N2 |
1.737520E-03 |
| N0-vs-N1 |
5.677000E-01 |
| N0-vs-N2 |
2.992600E-01 |
| N1-vs-N2 |
2.388000E-01 |
|
|
